Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial

Dale Bixby, Richard Noppeney, Tara L. Lin, Jorge Cortes, Jürgen Krauter, Karen Yee, Bruno C. Medeiros, Alwin Krämer, Sarit Assouline, Walter Fiedler, Natalie Dimier, Brian P. Simmons, Todd Riehl, Dawn Colburn

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)595-598
Number of pages4
JournalBritish Journal of Haematology
Volume185
Issue number3
DOIs
StatePublished - May 2019
Externally publishedYes

Keywords

  • Hedgehog signalling
  • leukaemia
  • stem cells
  • vismodegib

ASJC Scopus subject areas

  • Hematology

Cite this

Bixby, D., Noppeney, R., Lin, T. L., Cortes, J., Krauter, J., Yee, K., Medeiros, B. C., Krämer, A., Assouline, S., Fiedler, W., Dimier, N., Simmons, B. P., Riehl, T., & Colburn, D. (2019). Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial. British Journal of Haematology, 185(3), 595-598. https://doi.org/10.1111/bjh.15571